Aldosterone synthase inhibition in hypertension.

about

Relationship between plasma levels of vasoactive mediators and optic nerve head circulation shown by laser speckle flowgraphy.Nanocarriers as treatment modalities for hypertension.Metabolism of Oral Turinabol by Human Steroid Hormone-Synthesizing Cytochrome P450 Enzymes.

P2860

Q35761780-14D40E75-1716-4356-AB3B-357E65C3E066 Q38760963-C7C10593-D528-44E0-B8CA-F3796E7768DA Q52896121-CB72F079-5EC8-472D-B89F-A5669F8EB2AA

P2860

Aldosterone synthase inhibition in hypertension.

Item

http://www.wikidata.org/entity/Q38126805

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Aldosterone synthase inhibition in hypertension.

@en

type

Item

label

Aldosterone synthase inhibition in hypertension.

@en

prefLabel

Aldosterone synthase inhibition in hypertension.

@en

P1476

Aldosterone synthase inhibition in hypertension.

@en

P2093

Karl Andersen

http://www.w3.org/2001/XMLSchema#string

P2860

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

Structural insights into aldosterone synthase substrate specificity and targeted inhibition

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Discovery of selective CYP11B2 (aldosterone synthase) inhibitors for the therapy of congestive heart failure and myocardial fibrosis.

Arterial pressure, left ventricular mass, and aldosterone in essential hypertension.

Aldosterone production and insulin resistance in healthy adults

Rapid reversal of left ventricular hypertrophy and intracardiac volume overload in patients with resistant hypertension and hyperaldosteronism: a prospective clinical study

Impact of high-normal blood pressure on the risk of cardiovascular disease.

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

P2888

s11906-013-0379-7

P304

484-488

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11906-013-0379-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1032902912

http://www.w3.org/2001/XMLSchema#string

P698

23917810

http://www.w3.org/2001/XMLSchema#string

Aldosterone synthase inhibition in hypertension.

about

P2860

P2860

Aldosterone synthase inhibition in hypertension.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698